IL226038A0 - Compositions and methods for specific cleavage of exogenous rna in a cell - Google Patents

Compositions and methods for specific cleavage of exogenous rna in a cell

Info

Publication number
IL226038A0
IL226038A0 IL226038A IL22603813A IL226038A0 IL 226038 A0 IL226038 A0 IL 226038A0 IL 226038 A IL226038 A IL 226038A IL 22603813 A IL22603813 A IL 22603813A IL 226038 A0 IL226038 A0 IL 226038A0
Authority
IL
Israel
Prior art keywords
compositions
cell
methods
specific cleavage
exogenous rna
Prior art date
Application number
IL226038A
Other languages
English (en)
Hebrew (he)
Original Assignee
Nanodoc Ltd
Guy Abitbol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanodoc Ltd, Guy Abitbol filed Critical Nanodoc Ltd
Priority to IL226038A priority Critical patent/IL226038A0/en
Publication of IL226038A0 publication Critical patent/IL226038A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL226038A 2010-10-28 2013-04-28 Compositions and methods for specific cleavage of exogenous rna in a cell IL226038A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL226038A IL226038A0 (en) 2010-10-28 2013-04-28 Compositions and methods for specific cleavage of exogenous rna in a cell

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/IL2010/000895 WO2012056441A1 (en) 2010-10-28 2010-10-28 Compositions and methods for specific cleavage of exogenous rna in a cell
PCT/IL2011/000827 WO2012056449A2 (en) 2010-10-28 2011-10-27 Compositions and methods for specific cleavage of exogenous rna in a cell
IL226038A IL226038A0 (en) 2010-10-28 2013-04-28 Compositions and methods for specific cleavage of exogenous rna in a cell

Publications (1)

Publication Number Publication Date
IL226038A0 true IL226038A0 (en) 2013-06-27

Family

ID=45993240

Family Applications (1)

Application Number Title Priority Date Filing Date
IL226038A IL226038A0 (en) 2010-10-28 2013-04-28 Compositions and methods for specific cleavage of exogenous rna in a cell

Country Status (8)

Country Link
US (1) US20130225660A1 (enExample)
EP (1) EP2632931A4 (enExample)
JP (1) JP2013544510A (enExample)
CN (1) CN103282372A (enExample)
AU (1) AU2011322106A1 (enExample)
CA (1) CA2815632A1 (enExample)
IL (1) IL226038A0 (enExample)
WO (2) WO2012056441A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010500011A (ja) 2006-08-08 2010-01-07 ガンサー ハートマン ５’リン酸オリゴヌクレオチドの構造および使用
US9738680B2 (en) 2008-05-21 2017-08-22 Rheinische Friedrich-Wilhelms-Universität Bonn 5′ triphosphate oligonucleotide with blunt end and uses thereof
EP2508530A1 (en) 2011-03-28 2012-10-10 Rheinische Friedrich-Wilhelms-Universität Bonn Purification of triphosphorylated oligonucleotides using capture tags
EP2712870A1 (en) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Novel RIG-I ligands and methods for producing them
WO2017171654A1 (en) * 2016-04-01 2017-10-05 National University Of Singapore Trans-splicing rna (tsrna)
DE102017103383A1 (de) * 2017-02-20 2018-08-23 aReNA-Bio GbR (vertretungsberechtigter Gesellschafter: Dr. Heribert Bohlen, 50733 Köln) System und Verfahren zur Zelltyp-spezifischen Translation von RNA-Molekülen in Eukaryoten
WO2022182697A1 (en) * 2021-02-23 2022-09-01 Board Of Regents, The University Of Texas System A novel rna-based approach to cancer treatment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
EP0883344B2 (en) * 1995-12-15 2010-06-09 VIRxSYS Corporation Therapeutic molecules generated by trans-splicing
EP1147188B1 (en) * 1999-01-26 2007-05-16 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Internal ribosome entry site (ires), vector containing same and the uses thereof
WO2004050680A2 (en) * 2002-05-08 2004-06-17 Intronn, Inc. Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
US20030219407A1 (en) * 2002-05-15 2003-11-27 The Regents Of The University Of California RNA silencing in animals as an antiviral defense
AU2003247696A1 (en) * 2002-07-01 2004-01-19 E.I. Du Pont De Nemours And Company Method of controlling gene silencing using site-specific recombination
EP2000160A3 (en) * 2002-10-30 2009-03-11 Gambro Lundia AB Method and apparatuses for determining the efficiency of dialysis
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
WO2005112620A2 (en) * 2004-05-18 2005-12-01 Massachusetts Institute Of Technology A cre-lox based method for conditional rna interference
EP1799825B1 (en) * 2004-10-05 2011-06-29 The California Institute of Technology Aptamer regulated nucleic acids and uses thereof
JP5053850B2 (ja) * 2004-10-08 2012-10-24 バークシス コーポレーション 抗体遺伝子導入および抗体ポリペプチド産生のためのｒｎａトランススプライシングの使用
CN101184840A (zh) * 2005-03-31 2008-05-21 卡兰朵医药公司 核糖核苷酸还原酶亚基2的抑制剂及其用途
PL1866414T3 (pl) * 2005-03-31 2012-10-31 Calando Pharmaceuticals Inc Inhibitory podjednostki 2 reduktazy rybonukleotydowej i ich zastosowania
WO2007149246A2 (en) * 2006-06-12 2007-12-27 Massachusetts Institute Of Technology Cre-lox based gene knockdown constructs and methods of use thereof
US8158595B2 (en) * 2006-11-09 2012-04-17 California Institute Of Technology Modular aptamer-regulated ribozymes
WO2008106658A2 (en) * 2007-03-01 2008-09-04 California Institute Of Technology TRIGGERED RNAi
US8367815B2 (en) * 2007-08-28 2013-02-05 California Institute Of Technology Modular polynucleotides for ligand-controlled regulatory systems
US9029524B2 (en) * 2007-12-10 2015-05-12 California Institute Of Technology Signal activated RNA interference

Also Published As

Publication number Publication date
JP2013544510A (ja) 2013-12-19
EP2632931A2 (en) 2013-09-04
WO2012056449A2 (en) 2012-05-03
WO2012056441A1 (en) 2012-05-03
CA2815632A1 (en) 2012-05-03
US20130225660A1 (en) 2013-08-29
WO2012056449A3 (en) 2012-07-19
EP2632931A4 (en) 2014-06-18
AU2011322106A1 (en) 2013-05-30
CN103282372A (zh) 2013-09-04

Similar Documents

Publication Publication Date Title
EP2675918A4 (en) COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL
PT2591094T (pt) Método de produção de adamts13 recombinante em cultura celular
EP2635690A4 (en) COMPOSITIONS AND METHOD FOR PRODUCING FERMENTABLE SUGAR
IL214798A0 (en) Methods and compositions for stem cell cultures
IL242092A0 (en) A method for eukaryotic cell culture
PT3290528T (pt) Métodos e composições para sequenciamento de ácido nucleico
PT2683815E (pt) Derivados de piridinona como inibidores da transglutaminase tecidular
SG10201503666UA (en) Apparatus and methods for cell culture
SG10201608341XA (en) Cd40l expressing mammalian cells and their use
ZA201405122B (en) Methods and compositions for analyzing ahasl genes in wheat
EP2606123A4 (en) METHOD OF GENERATING OLIGOD DROCYTES AND CELL POPULATIONS THEREWITH
IL227529A0 (en) Compounds and methods of cell transplantation
EP2665814A1 (en) Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
HUE055340T2 (hu) Módszerek tenyészet életképességének fenntartására
EP2632931A4 (en) COMPOSITIONS AND METHOD FOR SPECIFIC CLIPPING OF EXOGENOUS RNA IN ONE CELL
EP2700707A4 (en) CELL CULTURE METHOD AND CELL CULTURE KIT
GB201013443D0 (en) Compositions and methods for producing dendritic cells
EP2699271A4 (en) METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING COMPONENTS THAT SELF-ASSEMBLED IN CELLS AND PRODUCE RNAI ACTIVITY
EP2616073A4 (en) INHIBITORS OF IMMERSION OF VIRUSES IN MAMMALIAN HOST CELLS
IL226170A0 (en) Compositions and methods for delivery of nucleic acids based on nanopolymers
GB201113641D0 (en) Cell culture support and cell culture method
IL226165A (en) Preparations and methods for the production of enterokines in yeast
GB201121101D0 (en) A method of preparing isolated cells and uses
GB201005736D0 (en) Electrolysis cell and method of operation
AU2010902612A0 (en) Methods for the maintenance and amplification of exogenous DNA in a cell